P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma-Reference-Cited by-同舟云学术

P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma

Published:2013-03-27 Issue:9 Volume:105 Page:606-607
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Ong Christy C.,Jubb Adrian M.,Jakubiak Diana,Zhou Wei,Rudolph Joachim,Haverty Peter M.,Kowanetz Marcin,Yan Yibing,Tremayne Jarrod,Lisle Richard,Harris Adrian L.,Friedman Lori S.,Belvin Marcia,Middleton Mark R.,Blackwood Elizabeth M.,Koeppen Hartmut,Hoeflich Klaus P.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/9/606/17313054/djt054.pdf

Reference45 articles.

1. The role of mitogen- and stress-activated protein kinase pathways in melanoma;Lopez-Bergami;Pigment Cell Melanoma Res,2011

2. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis;Lee;Br J Dermatol,2011

3. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

4. Oncogenic BRAF is required for tumor growth and maintenance in melanoma models;Hoeflich;Cancer Res,2006

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of downregulated NISCH expression in skin cutaneous melanoma: Modulation of tumor cell invasion, migration, and EMT via PAK1 inhibition;Tissue and Cell;2024-06

2. Somatic structural variants drive distinct modes of oncogenesis in melanoma;Journal of Clinical Investigation;2024-05-14

3. pXg: Comprehensive Identification of Noncanonical MHC-I–Associated Peptides From De Novo Peptide Sequencing Using RNA-Seq Reads;Molecular & Cellular Proteomics;2024-04

4. Somatic structural variants driving distinct modes of oncogenesis in melanoma;2023-11-04

5. Ivermectin as a potential therapeutic strategy for glioma;Journal of Neuroscience Research;2023-10-10